Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic

Abstract

Background We set out to investigate how the ongoing coronavirus pandemic affected the size of tumors and the duration of treatment delay in patients with surgically treated oral squamous cell carcinoma. Methods Patients with surgically treated oral cavity squamous cell carcinoma were assessed retrospectively and divided into two groups depending on when they had first presented at our clinic. Patients presenting from 2010 to 2019, that is, before COVID‐19 onset (n = 566) were compared to patients presenting in 2020 (n = 58). Results A total of 624 patients were included. Treatment delay was significantly longer in 2020 (median = 45 days) versus 2010–2019 (median = 35 days) (p = 0.004). We observed a higher pathological T classification in 2020 (p = 0.046), whereas pathological N classification was unchanged between groups (p = 0.843). Conclusions While extraordinary efforts continue to be made in the context of the pandemic, it is imperative that this does not lead to significant disadvantages for many people with oral cancer.

The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis

“…A delay in cancer treatment and disturbances in cancer care during the COVID-19 period was also reported by Schimdt et al, who outlined a significant disruption to cancer care during the pandemic and a decrease in outpatient visits at tertiary institutions in New York and Boston [ 28 ]. Similar findings were also reported in case of patients diagnosed with oral squamous cell carcinoma, with a treatment delay in 2020 of 45 days compared to 35 days in the 2010–2019 period ( p = 0.004) [ 29 ]. A systematic review concluded that patients and caregivers experienced delays in screening, treatment and care of cancer during the COVID-19 pandemic [ 30 ].…”

Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients

“…This leads to delays in intervention, a higher frequency of cystoscopy usage, increased time to treatment, and reduced compliance to maintenance strategy as reported by Ferro et al [ 47 ]. These observations are consistent with those of other medical institutions [ 48 , 49 ] and are also seen in the care of other cancers [ 50 , 51 , 52 ]. Although long-term overall implications are yet to be assessed, further delays and impediments in the management procedures would only increase the burden to patients and hospitals.…”

Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis

“…In the remaining months of 2020, however, a borderline significant trend towards higher proportion of stage IV tumours became apparent. The specific tumour growth rate of HNC is estimated at 1.8% per day and delays in presentation can easily lead to upstaging [28] , [29] , [30] .…”